These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29854766)

  • 1. Secondary Prevention of Cardiovascular Diseases and Application of Technology for Early Diagnosis.
    Karunathilake SP; Ganegoda GU
    Biomed Res Int; 2018; 2018():5767864. PubMed ID: 29854766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for cardiovascular disease prevention.
    Gupta R; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):15-34. PubMed ID: 21257098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The primary role of cardiologists in cardiovascular prevention].
    Onder L; Nicolosi GL
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):131S-132S. PubMed ID: 20879500
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.
    Godley RW; Hernandez-Vila E
    Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus.
    Srikanth S; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):47-70. PubMed ID: 21257100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acid in primary and secondary cardiovascular disease prevention.
    Chalupka S
    AAOHN J; 2009 Nov; 57(11):480. PubMed ID: 19968213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?
    Ridker PM; Koenig W; Kastelein JJ; Mach F; Lüscher TF
    Eur Heart J; 2018 Dec; 39(46):4109-4111. PubMed ID: 30452612
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins: have we found the Holy Grail?
    Jeger R; Dieterle T
    Swiss Med Wkly; 2012; 142():w13515. PubMed ID: 22315166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).
    Grützmacher P; Öhm B; Szymczak S; Dorbath C; Brzoska M; Kleinert C
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):22-26. PubMed ID: 28233269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol and inflammatory risk: Insights from secondary and primary prevention.
    Stock JK
    Atherosclerosis; 2019 Jan; 280():192-193. PubMed ID: 30458965
    [No Abstract]   [Full Text] [Related]  

  • 11. An Evaluation of FrancoForme: A CASE-MANAGED HOME-BASED PRIMARY AND SECONDARY CARDIOVASCULAR DISEASE PREVENTION PROGRAM FOR FRENCH-SPEAKING CANADIANS.
    Prince SA; Laflamme M; Harris J; Tulloch HE; de Margerie M
    J Cardiopulm Rehabil Prev; 2017 Nov; 37(6):437-444. PubMed ID: 27496248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editor's presentation.
    Piepoli MF
    Eur J Prev Cardiol; 2017 Jul; 24(10):1011-1013. PubMed ID: 28618853
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing Cardiovascular Disease.
    DiNicolantonio JJ; O'Keefe JH
    Prog Cardiovasc Dis; 2016; 58(5):463. PubMed ID: 26875628
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
    Lardizabal JA; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):87-103. PubMed ID: 21257102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beyond risk factors: priorities and new challenges of cardiovascular prevention].
    Urbinati S; Giampaoli S
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):7S-14S. PubMed ID: 20879472
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary and secondary prevention of cardiovascular disease: is there a place for Internet-based interventions?
    Pietrzak E; Cotea C; Pullman S
    J Cardiopulm Rehabil Prev; 2014; 34(5):303-17. PubMed ID: 25079147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Lowering Is Beneficial for Secondary Prevention but Not Primary Prevention in Patients 75 Years and Older.
    Ebell MH
    Am Fam Physician; 2021 Jun; 103(11):695-696. PubMed ID: 34060787
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trends and current questions of cardiovascular prevention in primary health care].
    Ilyés I; Jancsó Z; Simay A
    Orv Hetil; 2012 Sep; 153(39):1536-46. PubMed ID: 23000420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term management of patients at high cardiovascular risk in general practice].
    Filippi A;
    Monaldi Arch Chest Dis; 2009 Dec; 72(4):179-89. PubMed ID: 20183956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.